Giampiero Spalluto

Affiliations: 
University of Trieste, Italy, Trieste, Friuli-Venezia Giulia, Italy 
Google:
"Giampiero Spalluto"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Federico S, Margiotta E, Moro S, et al. (2021) Potent and selective A adenosine receptor antagonists bearing aminoesters as heterobifunctional moieties. Rsc Medicinal Chemistry. 12: 254-262
Grieco I, Bissaro M, Tiz DB, et al. (2021) Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems. European Journal of Medicinal Chemistry. 216: 113331
Pineux F, Federico S, Klotz KN, et al. (2020) Targeting G protein-coupled receptors with magnetic carbon nanotubes: The A3 adenosine receptor case. Chemmedchem
Federico S, Margiotta E, Moro S, et al. (2019) Conjugable A adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes. European Journal of Medicinal Chemistry. 111886
Federico S, Lassiani L, Spalluto G. (2019) Chemical Probes for the Adenosine Receptors. Pharmaceuticals (Basel, Switzerland). 12
Tan A, Babak MV, Venkatesan G, et al. (2019) Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy. Molecules (Basel, Switzerland). 24
Federico S, Margiotta E, Paoletta S, et al. (2019) Pyrazolo[4,3-][1,2,4]triazolo[1,5-]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an example. Medchemcomm. 10: 1094-1108
Federico S, Spalluto G. (2019) Functionalized ligands targeting G protein-coupled adenosine receptors. Future Medicinal Chemistry. 11: 1673-1677
Cheong SL, Federico S, Spalluto G, et al. (2019) The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy. Drug Discovery Today
Cacciari B, Crepaldi P, Cheng CY, et al. (2019) Structure Activity Relationship of 4-Amino-2-thiopyrimidine Derivatives as Platelet Aggregation Inhibitors. Medicinal Chemistry (Shariqah (United Arab Emirates))
See more...